I n patients at high risk for cardiovascular complications, the SPRINT (Systolic Blood Pressure Intervention Trial) recently showed that targeting a systolic blood pressure (SBP) of <120 mm Hg, as compared with the standard <140 mm Hg, results in lower rates of fatal and nonfatal major cardiovascular events and death from any cause.
I n patients at high risk for cardiovascular complications, the SPRINT (Systolic Blood Pressure Intervention Trial) recently showed that targeting a systolic blood pressure (SBP) of <120 mm Hg, as compared with the standard <140 mm Hg, results in lower rates of fatal and nonfatal major cardiovascular events and death from any cause. 1 However, this investigation had 2 important limitations. First, significant rates of adverse events were observed in the intensive treatment group, including syncope, hypotension, or electrolyte abnormalities. Second, patients with type 2 diabetes mellitus, who present the most severe comorbidities observed in hypertensive subjects, were totally excluded from the statistical evaluation.
Hypertension and diabetes mellitus are 2 major risk factors for cardiovascular morbidity and mortality. Epidemiological evidence shows the frequent association between hypertension and diabetes mellitus, indicating a substantial overlap in the pathophysiology of the 2 diseases, and leading to additive increases in the risk of cardiovascular events. 2 Several studies in the literature have shown that despite adequate glycemic and BP control, diabetic hypertensive subjects (DHS) remain at increased cardiovascular risk. [3] [4] [5] We recently showed that in DHS, evaluating increased aortic stiffness and enhanced pulse pressure (PP) and its amplification is an appropriate approach to independently determine the extent and severity of overall and cardiovascular risk (OCVR) in this population. We were also able to show that in age-and mean arterial pressure (MAP)-matched patients, aortic stiffness is significantly greater in DHS than in non-DHS subjects. [6] [7] [8] In addition, PP is influenced by 3 factors, that is, ventricular ejection, aortic stiffness, and wave reflections. With advancing age, the predictive value of increased aortic stiffness prevails over that of reduced ventricular ejection in the interpretation of increased PP, at least in subjects without heart failure.
The primary objective of this study was to assess OCVR factors in normotensive and hypertensive subjects divided into 2 different subgroups: those with and those without type 2 diabetes mellitus. Furthermore, in hypertensive subjects with diabetes mellitus, we used Cox regression models to identify the main criteria for predicting all-cause mortality. Based on our findings, we propose several hypotheses or factors, including PP, arterial stiffness, and lifestyle modifications, that are likely to be useful for both drug and nondrug therapies.
Methods
The study population was made up of individuals who attended the Clinical and Preventive Investigation Center (Centre d'investigation préventive et clinique [IPC] ), Paris, France). This medical center is subsidized by the French national healthcare system (Sécurité Sociale-CNAMTS) and offers all working and retired individuals and their families a free medical examination every 5 years. 9 It carries out ≈25 000 examinations per year for people living in the Paris area. Our study population included 344 536 individuals, of whom 244 816 (71%) had normal BP and 99 720 (29%) had hypertension. All were aged between 16 and 95 years and had attended a medical checkup at the IPC Center between January 1992 and December 2011.
The IPC Center was granted permission from the French National Data protection Agency (Commission nationale de l'informatique et des libertés [CNIL] ) and the French Advisory Committee on the Processing of Information for Medical research (Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé [CCTIRS] ) to conduct analyses on all data collected during the medical checkups. All participants gave informed consent at the time of the examination. In addition, at the end of the checkup, participants were also provided with medical counseling targeting relevant individual issues.
Investigations
Brachial BP was measured 3× using validated digital electronic devices (A & D model TM-2541; A&D Company, Tokyo, Japan). The mean of the last 2 measurements was calculated. Measurements were taken after a 10-minute rest in the supine position, and a resting ECG was also performed. Both body height (using a wall-mounted stature meter) and body weight (using calibrated scales) were recorded by a nurse. Standard laboratory parameters, including total plasma cholesterol, glycemia, and triglycerides, were assessed under fasting conditions as previously described. [6] [7] [8] Heart rate was calculated using the 10-cycle ECG (Cardionics ZM286LP; Cardionics SA, Brussels, Belgium). Lifestyle habits, personal and family medical history, and current medications were documented using a standardized self-administered questionnaire. Tea and coffee consumption was calculated using a 3-item variable for each beverage (no regular consumption, 1-4 cups per day, and >4 cups per day). γ-Glutamyl transferase was used as a surrogate index for alcohol consumption. Socio-occupational parameters were also assessed. Physical activity was determined by the yes/no question: do you regularly do some form of physical exercise equivalent to at least 1 hour walking per day? Tobacco consumption was classified into 3 groups: never smokers, ex-smokers, and current smokers. Information on education levels was limited to that available since January 2001.
Perceived stress and depression scores were calculated for each participant using validated self-administered questionnaires. Perceived stress was evaluated using Cohen's Perceived Stress Scale 10 that comprises at least 4 questions, while depression was evaluated using Pichot's Questionnaire of Depression, second abridged version, 11 which consists of 13 yes/no questions. All clinical and laboratory parameters were documented on the day of examination. To validate this procedure, in 2012, we assessed a random sample of 364 subjects considered as deceased in our database and compared the mortality data with those provided by city hall registries for every candidate. Discordance was found in only 2 cases (0.55%). On the basis of these findings, we considered that we had a complete database of deceased people for the entire study population.
Follow-Up
Follow-up ended in December 2011 (mean follow-up period, 12.7±6 years). During this time, 14 050 deaths (all-cause) were recorded. Causes of death were available up to 2008, and only 991 cardiovascular deaths were observed during this period.
Statistical Analysis
The study population was classified into 4 groups (I, II, III, and IV): (I) normotensive subjects without diabetes mellitus; (II) normotensive subjects with diabetes mellitus; (III) hypertensive subjects without diabetes mellitus; (IV) hypertensive subjects with diabetes mellitus. Hypertension was defined as SBP ≥140 mm Hg and diastolic blood pressure ≥90 mm Hg or the existence of antihypertensive drug therapy. Diabetes mellitus was defined as fasting glucose ≥126 mg/dL or existence of antidiabetic treatment. None of the patients were on hemodialysis or had undergone or were awaiting renal transplantation.
Brachial (BPP) and carotid PP (CPP) and the BPP/CPP ratio were calculated using multiple regression analysis associating BPP (measured by sphygmomanometer), several significant risk factors, and other hemodynamic and biochemical variables as previously described. 12 This method was validated by comparison with CPP values measured directly by pulse tonometry. Benetos et al 13 previously published a complete description of the procedure.
Multivariate analysis of variance was used to compare characteristics, including age and sex, of individuals in each group. Qualitative variables were compared using the χ 2 test. In each group, OCVR was associated with an increase of 10 mm Hg in BPP, CPP, MAP, and the BPP/CPP ratio, which was calculated using Cox regression models, including age, body mass index (BMI), tobacco consumption, physical activity, γ-glutamyl transferase, history of myocardial infarction, and cardiovascular events, mainly stroke, with hemodynamic risk factors.
In a second part of the analysis, we studied overall and cardiovascular mortality by comparing hypertensive subjects without diabetes mellitus to hypertensive subjects with diabetes mellitus. The methodology used was similar to that for the 4 groups (I, II, III, and IV). An interaction term between hemodynamic factors of BP and group effects was added to compare hypertension with diabetes mellitus and without diabetes mellitus.
14 Forward regression analysis was used to identify factors likely to explain the differences in mortality between the 2 groups.
Statistical analyses were performed using the SAS statistical software package (version 8.02, SAS Institute, Inc, Cary, NC). Table 1 shows the main characteristics of the population according to the presence of diabetes mellitus or hypertension. Results were all adjusted for age and sex. Significant differences were observed on all parameters between the group without hypertension or diabetes mellitus (reference group or group I) and each of the groups II, III, and IV. The reference group had lower BMI, cholesterolemia, glycemia, SBP, diastolic blood pressure, BPP, and CPP, as well as anxiety and depression scores. Compared with the other groups and after adjustment for age and sex, individuals in reference group I were seen to do physical activity more regularly and were more frequently classified as current smokers. All subjects had plasma creatinine <14 mg/L as shown in Table 1 . The prevalence of all-cause mortality and cardiovascular mortality was lower in the reference group, whereas the mortality risk (all-cause or cardiovascular) was seen to be higher in the group with both hypertension and diabetes mellitus (IV).
Results
The adjusted risk of all-cause and cardiovascular mortality associated with hemodynamic factors, based on the presence of diabetes mellitus or hypertension, and in the overall population is shown in Table 2 . BPP, CPP, and MAP were clearly associated with overall and cardiovascular mortality in the study population, whereas the BPP/CPP ratio was associated with all-cause mortality but not with cardiovascular mortality. The impact of hemodynamic factors in each group was compared using an interaction term (group×hemodynamic factors). The effect of BP hemodynamic factors on all-cause mortality was greater in the groups with hypertension. However, the impact of hemodynamic factors on cardiovascular mortality did not differ between the groups.
The second part of our analysis focused on the 2 groups of hypertensive individuals, with and without diabetes mellitus ( Table 3) . As shown in Table 1 , there were significant differences between the 2 groups in terms of the main patient characteristics and also in terms of overall cardiovascular mortality prevalence rates: 7.4% versus 14.0% for all-cause mortality in hypertensive subjects without diabetes mellitus and those with diabetes mellitus, respectively (P<0.0001), and 0.7% versus 1.3%, respectively (P<0.0001), for cardiovascular mortality. Note that the intergroup differences in terms of cholesterolemia and BPP were slight or nonexistent, whereas CPP was significantly lower in DHS than in non-DHS (42.6±0.9 versus 43.8±0.03; P<0.0001).
Groups of individuals with a history of myocardial infarction or cardiovascular events, mainly stroke, in the 2 hypertensive groups are shown in Figure. Differences between non-DHS and DHS groups were all statistically significant in terms of plasma creatinine (Table 1) , history of myocardial infarction (0.59% versus 1.54%; P<0.0001), and history of cardiovascular events, mainly stroke (0.79% versus 1.19%; P<0.0001), respectively (Figure) . Table 3 shows the overall and cardiovascular mortality rate associated with BP hemodynamic factors in both hypertensive groups. The interaction term (hypertensive with or without diabetes mellitus×hemodynamic factors) indicates that the impact of BP hemodynamic factors is similar in both groups. However, the different impacts of hemodynamic factors on mortality do not explain the differences in mortality rates between the 2 groups. Three Cox regression models show the specific role of each parameter studied in the prediction of all-cause mortality (14 050 individuals; Table 4 ). It is important to note that in the present study, this population included 991 subjects who died of cardiovascular causes. In model 1, which included a large number of risk factors but excluded level of education, anxiety, and depression, the differences in the risk of mortality between DHS and non-DHS remained highly significant (P=0.003), highlighting in particular the potential role of diabetes mellitus, BMI, and BPP and CPP. However, when level of education or depression and anxiety were included (Models 2 and 3 in Table 4 ), the differences between the 2 groups disappeared, suggesting that differences between DHS and non-DHS are possibly because of differences in the level of education or to the presence of depression or anxiety. Vascular activity was also an important factor to consider in the results.
Discussion
In this study, we assessed data from a large population of normotensive and hypertensive subjects divided into 4 groups: those with normal BP and no diabetes mellitus (Group I); those with normal BP and with diabetes mellitus (Group II); those with hypertension and without diabetes mellitus (Group III); and finally, those with both hypertension and diabetes mellitus (Group IV). We compared the 4 groups and observed that from the first to the fourth population, there was a progressive and substantial increase in OCVR. We compared DHS and non-DHS and in line with the main objective of the study, observed that the increased OCVR was particularly notable in the 2 hypertensive populations. The key question of this investigation was, therefore, to determine whether the differences between the various groups were associated with BP levels (or treatment) alone or whether other unidentified factor(s) were also involved.
The level of OCVR was calculated from measurements of steady (MAP) and pulsatile (PP) hemodynamic parameters because they are typically investigated in normotensive and particularly in hypertensive populations (Tables 2 and 3) . The degree of significance of our results is clearly unrelated to the use of multiple adjustments, in this case, essentially the role of age. We noted that during antihypertensive therapy, there were no significant interactions between hemodynamic factors (measured from MAP and PP) and overall or cardiovascular risk factors, thus, making it difficult to justify using these parameters to explain the difference in mortality between diabetic and nondiabetic hypertensive populations. This observation was clear from both our multigroup study (Table 2 ) and from our comparison of DHS and non-DHS subjects (Table 3 ). In contrast, in Table 4 , the level of vascular activity (Model 1), education (Model 2), as well as the depression and anxiety scores (Model 3) are clearly reliable predictors of mortality that merit further investigation.
One of the main findings of this investigation was the difference between our 2 categories of hypertensive subjects, those with and those without diabetes mellitus. DHS had a significantly higher incidence of cardiovascular events, principally characterized by myocardial infarction and cardiovascular events, mainly stroke, than non-DHS (Figure) . This observation is consistent with the high incidence of peripheral arterial disease commonly observed in diabetic subjects and, thus, with the presence of vascular factors, traditionally associated with atherosclerosis 15 and used as identifiable criteria for the cardiovascular risk in individuals with hypertension and diabetes mellitus (Group IV). In the present study, this finding was seen to be independent of BP levels. Aortic stiffness typically observed in hypertensive subjects was also seen to be significantly greater in DHS than in age-matched non-DHS with the same MAP. 6, 8 It seems likely that in DHS, this increased aortic stiffness may be one of the vascular factors, which, together with age, is the cause of vascular complications and potential cardiovascular accidents. 15 Our results highlight BP and aortic stiffness as factors associated with the complications observed in group IV, that is, hypertensive patients with type 2 diabetes mellitus. These potential complications are illustrated in the 3 Cox regression models (Table 4) we developed and where they are shown to be powerful predictors of mortality in DHS (Model 1). Three aspects of these models are particularly noteworthy because they have possible practical consequences.
First, Model 1 in Table 4 represents the risk of mortality associated with the study population of DHS. Clearly, this risk is significantly higher in DHS than in non-DHS. Note that the improvement expected from treatment is influenced by age and sex but also by education level and physical activity, which, therefore, play an important role in the prediction of overall mortality. Second, independent of any possible improvement provided by additional antihypertensive and anticholesterol drug therapy, glycemia and BMI would seem to have a particular impact on mortality (Table 4) . In this context, 2 specific characteristics of diabetes mellitus should be taken into consideration: the major influence of long-term antidiabetic treatment and the association with increased pulsatility and BMI (Table 4 ). The significant role of brachial and carotid pulsatility is clear in this context because it corresponds to steps 7 or 8 of Models 1, 2, and 3 of Table 4 and highlights the significance of the higher aortic stiffness that we observed in DHS as compared with non-DHS. [6] [7] [8] Third, long-term treatment regimens should take into consideration the influence of alcohol and tobacco consumption and, in some patients, that of anxiety and depression. Finally, the lack of physical activity is also a well-established major risk factor to consider. [16] [17] [18] [19] 
Perspectives
Our observations of DHS seem to differ from those of the SPRINT trial for several methodological reasons.
First, the results of the SPRINT trial were based exclusively on SBP and diastolic blood pressure measurements, whereas our study focused on the association of hypertension and diabetes mellitus. These 2 factors are widely recognized as responsible for the increased pulsatility observed in DHS [6] [7] [8] and justify further investigations into medial calcification, oxidative and inflammatory stress, advanced glycation end products, [18] [19] [20] and finally, the role of the vascular endothelium and smooth muscle cells in the context of concomitant hypertension and diabetes mellitus. 21, 22 Second, in the SPRINT trial, treatment consisted mainly of antihypertensive drugs and statins, whereas studies on mortality in DHS are more complex and involve not only stroke and cardiac prevention, but also treatments for alcohol or tobacco consumption, diabetes mellitus and depression, as well as specific therapies focusing on education and physical activity. 16, 17 The majority of these issues warrant prospective investigation not only based exclusively on SBP and diastolic blood pressure measurements, but also using studies on education and physical activity, as well as on pulsatility and wave reflections. Note that some of these parameters have already been shown to be significantly modified by antihypertensive drug treatment. [23] [24] [25] These factors should all be taken into thorough consideration in the future. Three different models are proposed. Model 1: Age, BMI, tobacco consumption, physical activity, glycemia, cholesterol, brachial PP, central PP, γ-GT, history of myocardial infarction, stroke, and diabetes mellitus effect. Model 2: Model 1+education level. Model 3: Model 1+depression and anxiety. BMI indicates body mass index; γ-GT, γ-glutamyl transferase; and PP, pulse pressure.
*Effect of diabetes mellitus on mortality in hypertensive group. †Percent of subjects with >2 y higher education beyond high school diploma (data available up to 2001).
